Latest Trials
| EudraCT Number: 2005-001171-36 | Sponsor Protocol Number: TG-MV-001 | Start Date: 2005-05-13 | ||||||
| Sponsor Name: ThromboGenics Ltd. | ||||||||
| Full Title: A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy | ||||||||
| Medical condition: Vitreomacular Traction Maculopathy | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: BE (Completed) GB (Completed) | ||||||||
| Trial results: View results | ||||||||
| EudraCT Number: 2004-004509-11 | Sponsor Protocol Number: dopa_HSP | Start Date: 2005-05-13 | ||||||
| Sponsor Name: University hospital of the University of Ulm | ||||||||
| Full Title: Efficiency and tolerability of L-Dopa in patients with Hereditary Spastic Paraplegia (HSP) | ||||||||
| Medical condition: Hereditary spastic paraplegias (HSP) are a rare neurodegenerative group of disorders characterised by slowly progressive symmetric spastic paraparesis, distal pallhypaesthesia of the lower limbs, a... | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: DE (Ongoing) | ||||||||
| Trial results: (No results available) | ||||||||
| EudraCT Number: 2004-002620-18 | Sponsor Protocol Number: IM101-046 | Start Date: 2005-05-13 | ||||||
| Sponsor Name: Bristol-Myers Squibb International Corporation | ||||||||
| Full Title: A Multi-National Randomized, Double-Blind, Exploratory Study of Abatacept versus Placebo in Preventing the Development of Rheumatoid Arthritis in Adult Subjects with Undifferentiated Inflammatory A... | ||||||||
| Medical condition: Rheumatoid Arthritis, NOS | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: DE (Completed) GB (Completed) BE (Completed) IT (Completed) ES (Completed) | ||||||||
| Trial results: (No results available) | ||||||||
| EudraCT Number: 2005-000361-19 | Sponsor Protocol Number: CSPP100A2242 | Start Date: 2005-05-13 | ||||||
| Sponsor Name: Novartis Pharma Services AG | ||||||||
| Full Title: An open-label, one-period, one-treatment study which objective is to evaluate the time course of the antiproteinuric and blood pressure lowering effect of renin inhibition with Aliskiren in patient... | ||||||||
| Medical condition: Hypertension | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: DK (Completed) | ||||||||
| Trial results: View results | ||||||||
| EudraCT Number: 2004-004901-12 | Sponsor Protocol Number: SFOLFOX/SFOLFIRI vs FOLFOX/FOLFIRI | Start Date: 2005-05-13 | |||||||||||
| Sponsor Name: TEVA Pharma Belgium | |||||||||||||
| Full Title: Phase II randomized study of Combined Infusional Leucovorin Sodium and 5-FU Versus the Classical Sequential administration of Leucovorin Calcium followed by 5-FU both in combination with standard ... | |||||||||||||
| Medical condition: Histologically confirmed adenocarcinoma of the colon or the rectum and unresectable metastases or advanced locoregional disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-000706-31 | Sponsor Protocol Number: IMMU-103-04 | Start Date: 2005-05-13 | |||||||||||
| Sponsor Name: Immunomedics, Inc. | |||||||||||||
| Full Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Studyof Epratuzumab in Patients with Active Systemic Lupus Erythematosus | |||||||||||||
| Medical condition: Systemic Lupus Erythematosus | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) DE (Prohibited by CA) BE (Completed) IT (Prematurely Ended) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-002106-29 | Sponsor Protocol Number: ET-743-STS-201 | Start Date: 2005-05-13 | |||||||||||
| Sponsor Name: Pharma Mar SA Unipersonal | |||||||||||||
| Full Title: A Randomized, Multicenter, Open-label Study of YONDELIS ™ (ET-743 ecteinascidin) Administered by 2 Different Schedules (Weekly for 3 of 4 weeks vs. q3 Weeks) in Subjects With Locally Advanced or Me... | |||||||||||||
| Medical condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) IT (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-004586-14 | Sponsor Protocol Number: BILA 1704/RAE | Start Date: 2005-05-13 | ||||||
| Sponsor Name: FAES FARMA S.A. | ||||||||
| Full Title: Double-blind, randomised, placebo-controlled, phase III study comparing the efficacy and safety of bilastine 20 mg once daily and cetirizine 10 mg for the treatment of allergic allergic rhinitis | ||||||||
| Medical condition: Seasonal Allergic Rhinitis | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: CZ (Completed) BE (Completed) DE (Completed) ES (Ongoing) | ||||||||
| Trial results: (No results available) | ||||||||
| EudraCT Number: 2004-000502-40 | Sponsor Protocol Number: RHM CAN0380 | Start Date: 2005-05-13 | ||||||
| Sponsor Name: Southampton University Hospitals Trust | ||||||||
| Full Title: A thematic analysis of semi-structured interviews using a phenomenological approach into palliative care patients experiences of change in "fatigue" following treatment with methylphenidate – an ex... | ||||||||
| Medical condition: Patients with cancer in palliative stage of their illness. Suffering from fatigue with or without decreased concentration, depression or drowsiness, who feel their fatigue is severe enough to decre... | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||
| Trial results: (No results available) | ||||||||
| EudraCT Number: 2004-004021-98 | Sponsor Protocol Number: MO 18458 | Start Date: 2005-05-12 | |||||||||||
| Sponsor Name: ROCHE | |||||||||||||
| Full Title: A single arm phase IV study to assess efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-fluorouracil/folinic acid regimens as first line treatment for patients with... | |||||||||||||
| Medical condition: metastatic colorectal carcinoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||